Login / Signup

Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial.

Sanne Y Smith-ApeldoornJolien K E VeraartJeanine KamphuisAntoinette D I van AsseltDaan J TouwMarije Aan Het RotRobert A Schoevers
Published in: BMC psychiatry (2019)
Dutch Trial Register, NTR6161. Registered 21 October 2016.
Keyphrases
  • phase iii
  • study protocol
  • depressive symptoms
  • phase ii
  • clinical trial
  • sleep quality